Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Search

Page Path
HOME > Search
1 "Thomas Massarvva"
Filter
Filter
Article category
Keywords
More +
Publication year
Authors
COVID-19: Systematic Review
Clinical outcomes of COVID-19 amongst HIV patients: a systematic literature review
Thomas Massarvva
Epidemiol Health. 2021;43:e2021036.   Published online May 17, 2021
DOI: https://doi.org/10.4178/epih.e2021036
  • 14,776 View
  • 417 Download
  • 3 Web of Science
  • 2 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The global pandemic coronavirus disease 2019 (COVID-19) emerged in the city of Wuhan, China around December 2019. Since then, the virus has caused severe morbidity and mortality worldwide and has put pressure on the global medical system. Still, there are limited data regarding the clinical impact of COVID-19 on people living with human immunodeficiency virus (HIV). The primary aim of this study was, therefore, to systematically review up-to-date studies reporting the clinical outcomes of COVID-19 amongst HIV patients.
METHODS
A thorough literature search was carried out using MEDLINE, Embase, Scopus, and the Cochrane Library Databases in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
RESULTS
A total of 22 studies were identified. Amongst 730 HIV/COVID-19-coinfected patients, 79.4% were males, the median age was 51.5 years, and the number of reported patients receiving antiretroviral drugs was 708 (97.2%). Most coinfected patients had mild to moderate symptoms, including cough (37.7%), fever (37.5%), and dyspnoea (24.7%). Among pre-existing comorbidities, hypertension (26.3%) was the most prevalent in HIV/COVID-19 coinfected patients, and 87% of coinfected patients recovered.
CONCLUSIONS
Based on the existing data in this systematic literature review, HIV patients with pre-existing comorbidities, obesity, and older age should be considered as a high-risk group for COVID-19. Furthermore, coinfected patients appear to have marginally comparable clinical outcomes with the general population. The study’s findings highlight the need for further investigation to elucidate the impact of COVID-19 infection on HIV patients.
Summary
Key Message
In this systematic literature review, various aspects of COVID-19 outcomes amongst HIV patients are identified and quantified, including the proportion of different symptoms, severity, pre-existing comorbidities, recovery, death, and the most commonly prescribed antiretroviral drugs in HIV patients with COVID-19 coinfection.

Citations

Citations to this article as recorded by  
  • Double Trouble Co-Infections: Understanding the Correlation Between COVID-19 and HIV Viruses
    Sassi Ashraf Ali Abbasi, Tarika Noor, Maneeth Mylavarapu, Monika Sahotra, Hunmble A Bashir, Rakshita Ramesh Bhat, Urmi Jindal, Uzma Amin, Anushree V, Humza F Siddiqui
    Cureus.2023;[Epub]     CrossRef
  • HIV and COVID-19: review of clinical course and outcomes
    Lauren K. Barbera, Kevin F. Kamis, Sarah E. Rowan, Amelia J. Davis, Soraya Shehata, Jesse J. Carlson, Steven C. Johnson, Kristine M. Erlandson
    HIV Research & Clinical Practice.2021; 22(4): 102.     CrossRef
Epidemiol Health : Epidemiology and Health
© Korean Society of Epidemiology.
TOP